Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Krystal Biotech, Inc.(NasdaqGM:KRYS) added to Russell Small Cap Comp Value Index

06/25/2021 | 12:00am EDT

Krystal Biotech, Inc.(NasdaqGM:KRYS) added to Russell Small Cap Comp Value Index


© S&P Capital IQ 2021
All news about KRYSTAL BIOTECH, INC.
09/16KRYSTAL BIOTECH : Guaranteed Maximum Price Amendment (Form 8-K)
PU
09/16KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial St..
AQ
09/15Krystal Biotech Appoints Laurent Goux as General Manager of Europe
GL
09/09KRYSTAL BIOTECH : to Present Data on DEB and B-VEC at the DEBRA International Co..
AQ
09/07KRYSTAL BIOTECH : to Participate in H.C. Wainwright 23rd Annual Global Investmen..
AQ
08/19KRYSTAL BIOTECH : Regulation FD Disclosure (form 8-K/A)
AQ
08/09KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Regulatio..
AQ
08/09KRYSTAL BIOTECH : Q2 Loss Widens
MT
08/09KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
08/09Krystal Biotech, Inc. Reports Earnings Results for the Second Quarter Ended J..
CI
More news
Analyst Recommendations on KRYSTAL BIOTECH, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -84,8 M - -
Net cash 2021 339 M - -
P/E ratio 2021 -19,6x
Yield 2021 -
Capitalization 1 314 M 1 314 M -
EV / Sales 2021 -
EV / Sales 2022 3,34x
Nbr of Employees 75
Free-Float 75,4%
Chart KRYSTAL BIOTECH, INC.
Duration : Period :
Krystal Biotech, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KRYSTAL BIOTECH, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 59,19 $
Average target price 98,43 $
Spread / Average Target 66,3%
EPS Revisions
Managers and Directors
Krish S. Krishnan Chairman, President & Chief Executive Officer
George Chen Manager-Information Technology & CSV
Trevor Parry Director-IP & Scientific Affairs
Brittani Agostini Manager-Clinical Operations
Court Freedman Senior Scientist
Sector and Competitors
1st jan.Capi. (M$)
KRYSTAL BIOTECH, INC.-1.35%1 314
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
WUXI APPTEC CO., LTD.35.75%69 350
REGENERON PHARMACEUTICALS34.93%67 775
VERTEX PHARMACEUTICALS-20.33%48 850